Menu
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Services Overview
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
    • Novum CRA Academy
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
  • The Novum Advantage
    • The Difference
    • Case Studies
  • Services
    • Services Overview
    • Scientific Affairs
    • Phase I Early Clinical Development
    • Bioanalytical
    • Biosimilars
    • Phase II-IV Clinical Trial Management
    • Data Management
  • Company
    • Company Overview
    • Mission and Values
    • History
    • Leadership
    • Facility and Features
  • News
  • Careers
    • Careers Overview
    • Open Positions
    • Novum CRA Academy
  • Contact
    • General Inquiries
    • Business Development Inquiries
    • Request a Quote
    • Investigators
    • Employment Opportunities
  • Lambda
  • Participate in a study
Company

Facility and Features

 

Three geographically diverse sites spanning the US and Canada allow Novum to accommodate multiple needs and be flexible with capacity.

Novum US— Las Vegas NV, Fargo ND.

  • 410-bed total
  • Confined and outpatient studies
  • Dedicated procedure areas
  • Over 30,000+ diverse participant database
  • Accessible to public transportation
  • Adjacent to universities and medical centers
  • Centralized atomic clock system
  • Schedule II-V: DEA Registration
  • Controlled Substance II – V Registration Certificate.
  • Freezers: security-alarmed -80°C and -20°C
  • Negative-pressure dosing chamber

Novum Canada—Toronto, Canada.

  • 140 regular and 12 beds for close monitoring
  • Can accommodate large panels, institutionalized, and patient based and mixed population studies
  • Proximity to emergency hospital
  • Biometric system in place to avoid cross participation
  • EDC platform for clinical operations
  • Capability to store and dispense controlled drugs
  • Active Database of 25,000+ participants

Access to Special populations

  • Diabetes
  • Hypertension
  • Obesity
  • Smokers
  • Postmenopausal females
  • Surgically Sterile females
  • Hyperlipidemia

 

 

  • Company Overview
  • Mission and Values
  • History
  • Leadership
  • Facility and Features
  • Company Overview
  • Mission and Values
  • History
  • Leadership
  • Facility and Features

225 W. Station Square Drive
Suite 200
Pittsburgh, PA 15219

© 2023, Novum. All rights reserved.Privacy Policy

Site by Imagebox

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.

OkNo